<Record><identifier xmlns="http://purl.org/dc/elements/1.1/">URN:NBN:SI:doc-X3ARWM0T</identifier><date>2022</date><creator>Liu, Yang</creator><relation>documents/doc/X/URN_NBN_SI_doc-X3ARWM0T_001.pdf</relation><relation>documents/doc/X/URN_NBN_SI_doc-X3ARWM0T_001.txt</relation><format format_type="issue">4</format><format format_type="volume">56</format><format format_type="type">article</format><format format_type="extent">str. 479-487, VII</format><identifier identifier_type="DOI">10.2478/raon-2022-0047</identifier><identifier identifier_type="ISSN">1318-2099</identifier><identifier identifier_type="COBISSID">229659395</identifier><identifier identifier_type="URN">URN:NBN:SI:doc-X3ARWM0T</identifier><language>eng</language><publisher publisher_location="[Zagreb]">Croatian Medical Association - Croatian Society of Radiology</publisher><publisher publisher_location="Ljubljana">Slovenian Medical Society - Section of Radiology</publisher><source>Radiology and oncology (Ljubljana)</source><rights>BY</rights><subject language_type_id="slv">bezgavke</subject><subject language_type_id="slv">karcinom nosnega žrela</subject><subject language_type_id="slv">kemoradioterapija</subject><subject language_type_id="slv">magnetna resonanca</subject><subject language_type_id="slv">nazofaringralni rak</subject><subject language_type_id="slv">onkologija</subject><title>MRI-identified multidimensional nodal features predict survival and concurrent chemotherapy benefit for stage II nasopharyngeal carcinoma</title></Record>